SCHEMBL3357749

SCHEMBL3357749

O=[N+]([O-])c1ccc2cnn(C3CCNCC3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 2/20 0.43
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
CYP1A2 P05177 1/20 0.43
SLC6A4 P31645 1/20 0.43
CYP2C19 P33261 1/20 0.43
THPO P40225 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
ALOX15 P16050 2/20 0.40
GLS O94925 1/20 0.40
NOS1 P29475 1/20 0.40
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3354657 0.91 GLS (0.49) ALDH1A1CYP3A4HTR3EHTR3BCYP1A2
SCHEMBL29741245 0.91 GLS (0.44) ALDH1A1CYP3A4HTR3EHTR3BCYP1A2
SCHEMBL3388874 0.91 GLS (0.44) ALDH1A1CYP3A4HTR3EHTR3BCYP1A2
SCHEMBL30778513 0.88 MAPT (0.46) ALDH1A1CYP3A4LMNAMAPTALOX15
SCHEMBL3356604 0.84 HTR1A (0.52) MAPTALOX15GLSPRMT5PKM
SCHEMBL31304459 0.82 GLS (0.53) ALDH1A1CYP3A4HTR3EHTR3BCYP1A2
SCHEMBL14910335 0.82 GLS (0.53) ALDH1A1CYP3A4HTR3EHTR3BCYP1A2
SCHEMBL3353374 0.81 ALDH1A1 (0.48) ALDH1A1CYP1A2LMNAMAPTGLS
SCHEMBL1868072 0.81 L3MBTL1 (0.43) CYP1A2LMNAGLSTDP1
SCHEMBL3352833 0.81 MAPT (0.45) ALDH1A1CYP1A2LMNAMAPTGLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed